DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Repligen Corp (NASDAQ: RGEN)

34.75 -0.25 (-0.71%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

RGEN $34.75 -0.71%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $35.16
Previous Close $35.00
Daily Range $34.46 - $35.16
52-Week Range $14.92 - $35.47
Market Cap $1.1B
P/E Ratio 140.00
Dividend (Yield) $0.00 (0.0%)
Volume 273,883
Average Daily Volume 503,300
Current FY EPS $0.31




Drug Makers

Repligen Corp (RGEN) Description

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system. Website:

News & Commentary Rss Feed

Is This Tiny Biotech Still a Buy at All-Time Highs?

Repligen may not be on your watchlist, but it has been (very) good to investors in recent years. Will the ride continue?

Perilous Reversal Watch: Repligen (RGEN)

Insider Trading Alert - RGEN, FGP And PSEM Traded By Insiders

A Tech Stocks Update for 2015

Repligen (RGEN) Enters Overbought Territory - Tale of the Tape

New Lifetime High Today: Repligen (RGEN)

The Hottest Opportunities in Tech Right Now

Repligen's (RGEN) CEO Walter Herlihy on Q4 2014 Results -- Earnings Call Transcript

Why Repligen Corporation Shares Manufactured a 13% Gain Today

Repligen Corporation shares rocketed higher. Here's what you need to know.

Friday's ETF Movers: PBE, PIN

See More RGEN News...

RGEN's Top Competitors

RGEN $34.75 (-0.71%)
Current stock: RGEN
AMGN $167.91 (-0.74%)
Current stock: AMGN
GILD $103.70 (-1.44%)
Current stock: GILD
BIIB $401.71 (-6.64%)
Current stock: BIIB